Banks Jerel A. 4
4 · Benitec Biopharma Inc. · Filed Mar 8, 2024
Insider Transaction Report
Form 4
Banks Jerel A.
DirectorChief Executive Officer
Transactions
- Award
Options (right to buy)
2024-03-06+466,554→ 466,554 totalExercise: $5.21Exp: 2034-03-06→ Common Stock (466,554 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027.